Finoriq research workspace
HeartBeam, Inc. (BEAT) Historical Metrics
HeartBeam, Inc. operates as a medical technology company that focuses on developing. Review BEAT valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
- Company
- HeartBeam, Inc. (BEAT)
- Ticker
- BEAT
- Market Cap
- $31.4M
- Latest Price
- $0.566
- Industry
- Medical Devices
HeartBeam, Inc. (BEAT) Current Valuation Metrics
Static valuation preview for HeartBeam, Inc. (BEAT). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -57.0% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -36.9% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 55.9x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.